Author: Ashley Myers

  • New eNOA Distribution Process

    Authors: Edwin Bemmel, AVP, (RGC) & Jumionne Tiako, Director, Post-Award Setup/Close, (RGC) We are thrilled to announce improvements to the distribution of our electronic Notice of Award (eNOA) designed to enhance transparency, streamline processes, and provide faster, greater efficiency for our faculty. What’s New As of August 15, 2024, eNOAs are now sent directly to…

  • Enjoy Faster Processing Times with OTT’s Outgoing Low-Risk DUAs Process

    Author: Asher Alt, Marketing Specialist, (OTT) Most outgoing data use agreements (DUAs) leaving Emory are classified as low-risk. To streamline and expedite their processing times, OTT implemented a new strategy earlier this year: giving Emory PIs and research teams control of executing these types of contracts. This is a win-win for everyone: More control for…

  • Gene Drive: Risks and Benefits

    Authors: Kalpana Rengarajan, PhD; Rashida Moore, DVM, DACLAM Gene drives refer to genetic elements that skew the pattern of inheritance of a given characteristic in sexually reproducing organisms. They can be used to spread a characteristic that can alter or even reduce the numbers of individuals in wild populations of a certain species. As they…

  • December 2024 Insight Project Updates

    Authors: Cindy Cha, Sr. Project Support Specialist (RBO) & Kim Maune, Emory Chief Implementation Officer, Insight GMS Phase 1: New Expertise, Enhanced Environment, Validation Efforts We’re excited to welcome Amy Andrade, Director of Research Informatics, to lead integration and migration efforts. Amy will oversee integration & migration efforts, supervise our Global Innovation data engineers and…

  • Holiday Greetings from the Office of Research Administration

    Dear Colleagues, As the holiday season approaches, I want to take a moment to extend my heartfelt gratitude for your dedication and partnership in advancing research excellence at Emory University. Your tireless efforts and unwavering commitment to our mission continue to inspire and drive impacts in our communities; while also enhancing research administrative processes across…

  • Coming in May 2025: Investigators Must Use SciENcv To Format NIH and NSF Personnel Documents

    Authors: Deepika Bhatia, AVP, (RCRA) & Kimberly Eck, Sr. AVP, (SVPR) SciENcv is an application in My NCBI that helps you create and manage documents in support of grant applications with participating agencies. In SciENcv you can document your education, employment, research activities, publications, honors, research grants, and other professional contributions. https://www.ncbi.nlm.nih.gov/sciencv/ For NIH: Biosketches…

  • Effective January 25, 2025 – A Revised NIH Grant Review Process with a Focus on Scientific Merit & Reputational Bias Reduction

    By: Erica Pitre, Office of Research Development The National Institutes of Health (NIH) has taken steps to simplify its grant review process for most research project grants for applications with due dates of January 25, 2025 or later. Upcoming changes have been undertaken in order to address the complexity of the peer review process and…

  • Grant Forward at Emory University

    Author: Cortney Levine, Office of Research Development The Office of the Senior Vice President for Research sponsors a university-wide subscription to GrantForward.  GrantForward provides easy, customizable access to thousands of grant opportunities through a single easy-to-use interface. Researchers can use this service to self-curate personalized funding notices, as well as to create research profiles that…

  • Effective October 1: IRB Protocol and Consent Template Updates

    The IRB has released new protocol and consent templates for biomedical research, available on the IRB website. Additional templates will be updated in the near future. Biomedical Protocol updates include: Clarity around information needed Attestation checkboxes Removal of the checklist DSMP questionnaire now embedded within the protocol Updated DSMP charts Biomedical Consent updates include: More…

  • H5 Avian Influenza Virus Exemption

    Authors: Kalpana Rengarajan, PhD & Rashida Moore, DVM Select agents are biological agents and toxins that have the potential to pose a severe threat to both human and animal health, plant health, or to animal and plant products. These materials are regulated by the Federal Select Agent Program, under 7 CFR Part 331, 9 CFR…